EDITOR'S NOTE
Is capecitabine the “AC” of adjuvant therapy for colorectal cancer?
Neil Love, MD

FACULTY INTERVIEWS
Leonard B Saltz, MD
Professor of Medicine
Weill College of Cornell University
Attending Physician
Colorectal Disease Management Team Leader
Memorial Sloan-Kettering Cancer Center
New York, New York
- Select publications

Paulo M Hoff, MD
Associate Professor of Medicine
The University of Texas MD Anderson Cancer Center
Houston, Texas
- Select publications

Michael J O’Connell, MD
Professor of Human Oncology
Drexel University School of Medicine
Director, Allegheny Cancer Center
Director, Division of Medical Oncology
Allegheny General Hospital
Associate Chairman
National Surgical Adjuvant Breast and Bowel Project
Pittsburgh, Pennsylvania
- Select publications

Editor's office

CME Information

Faculty disclosures